David P. Dearnaley
0000-0002-3954-2806
Publication & Citation Trends
Publications
0 total
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS Study OA
Cited by 3
Semantic Scholar
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial. OA
Cited by 99
Semantic Scholar
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer OA
Cited by 23
Semantic Scholar
1837P Assessing PSA
Cited by 0
Semantic Scholar
New horizons for prostate cancer: part 1
Cited by 1
Semantic Scholar
Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial. OA
Cited by 12
Semantic Scholar
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping
Cited by 179
Semantic Scholar
Seven novel prostate cancer susceptibility loci identified by a multi-stage genome-wide association study OA
Cited by 287
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(329)
Prostate Cancer Diagnosis and Treatment
(304)
Advanced Radiotherapy Techniques
(194)
Effects of Radiation Exposure
(60)
Radiopharmaceutical Chemistry and Applications
(55)
Affiliations
University of London
National Health Service
Western University
Fox Chase Cancer Center
BC Cancer Agency
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.